Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Eur J Pharm Sci ; 102: 172-179, 2017 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-28279763

RESUMO

A doubly enteric-coated multiple-unit tablet (DET) of bisacodyl (BD) was formulated to selectively deliver the stimulant laxative to the large intestine. Solubilized BD in surfactants was adsorbed into the porous carrier and primarily coated with different combinations of pH-sensitive polymers (Eudragit S and Eudragit L) and time-dependent release polymer (Eudragit RS). BD-loaded granules were compressed into tablets and coated again with pH-sensitive polymers (Eudragit S:Eudragit L=1:1). The multiple-unit tablet was optimized with respect to the granular coating compositions (Eudragit S:Eudragit L:Eudragit RS=5:1:4) and coating level (12.5%), and coating level on the tablet (25%), by evaluating in vitro release profile in continuous dissolution medium. Drug release from the optimized tablet was effectively retarded in the simulated gastric and small intestinal fluids (below 7%), but profound drug liberation was attained in the colonic fluid (over 50%). On the other hand, drug release from the marketed product (Dulcolax®, Boehringer Ingelheim Pharma), a reference drug, in the gastric and small intestinal fluids was reached to 30%, while that in the colonic fluid was only 7%. In an in vivo efficacy study in loperamide-induced constipated rabbits, a remarkable recovery in fecal secretion was observed in the DET-treated group 24h post-dosing, compared to vehicle-treated (p<0.05) and the marketed product-treated groups (p<0.05). Moreover, pharmacokinetic evaluation in the constipated rabbits revealed that the DET system significantly lowered the systemic exposure compared with the marketed product (p<0.05), by hindering drug release in the upper intestine, a preferential absorption site. Therefore, the novel colon-targeted delivery system may be an alternative for boosting pharmacological responses in the colon, while diminishing the intestinal irritation and/or systemic adverse effect of the stimulant laxative.


Assuntos
Bisacodil/administração & dosagem , Sistemas de Liberação de Medicamentos , Mucosa Intestinal/metabolismo , Laxantes/administração & dosagem , Resinas Acrílicas/administração & dosagem , Resinas Acrílicas/química , Animais , Bisacodil/química , Bisacodil/farmacocinética , Bisacodil/uso terapêutico , Constipação Intestinal/tratamento farmacológico , Constipação Intestinal/metabolismo , Liberação Controlada de Fármacos , Excipientes/administração & dosagem , Excipientes/química , Suco Gástrico , Concentração de Íons de Hidrogênio , Absorção Intestinal , Secreções Intestinais , Laxantes/química , Laxantes/farmacocinética , Laxantes/uso terapêutico , Coelhos , Solubilidade , Comprimidos com Revestimento Entérico/administração & dosagem , Comprimidos com Revestimento Entérico/química
2.
Biotechnol Prog ; 20(3): 890-6, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15176896

RESUMO

Auxotrophic strains of Agrobacterium tumefaciens were generated for use in liquid co-culture with plant tissue for transient gene expression. Twenty-one auxotrophs were recovered from 1,900 tetracycline-resistant insertional mutants generated with a suicide vector transposon mutagenesis system. Twelve of these auxotrophs were characterized on a nutrient matrix. Isolates were screened for growth in plant cell and root culture, and three auxotrophs were identified that had limited growth: adenine (ade-24), leucine (leu-27), and cysteine (cys-32). Ade-24 displayed poor T-DNA delivery in a transient expression test delivering GUS from a binary vector, while cys-32 displayed the best ability to deliver DNA of these three auxotrophs. The growth yield of cys-32 on cysteine was assessed to provide a quantitative basis for co-culture nutrient supplementation. The utility of cys-32 for delivering T-DNA to plant tissues is demonstrated, where an 85-fold enhancement in GUS expression over wild-type A. tumefaciens was achieved.


Assuntos
Agrobacterium tumefaciens/genética , Técnicas de Transferência de Genes , Engenharia Genética/métodos , Nicotiana/genética , Nicotiana/microbiologia , Plantas Geneticamente Modificadas/genética , Plantas Geneticamente Modificadas/microbiologia , Agrobacterium tumefaciens/classificação , Agrobacterium tumefaciens/isolamento & purificação , Agrobacterium tumefaciens/metabolismo , Células Cultivadas , Técnicas de Cocultura/métodos , Estudos de Viabilidade , Genes Reporter/genética , Vetores Genéticos/genética , Glucuronidase/biossíntese , Glucuronidase/genética , Plantas Geneticamente Modificadas/metabolismo , Proteínas Recombinantes/biossíntese , Especificidade da Espécie , Nicotiana/crescimento & desenvolvimento , Nicotiana/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA